A risk score for unfavorable outcome in adults with bacterial meningitis

Annals of Neurology

Volumn 63, Issue 1, 2008, Pages 90-97

  Weisfelt, Martijn ^a   Van De Beek, Diederik ^a   Spanjaard, Lodewijk ^a   Reitsma, Johannes B ^a   De Gans, Jan ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE;

ADULT; AGE; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; FEMALE; GLASGOW OUTCOME SCALE; GRAM POSITIVE COCCI; HEART RATE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; ARRHYTHMIAS, CARDIAC; CEREBROSPINAL FLUID; COHORT STUDIES; COMORBIDITY; CRANIAL NERVE DISEASES; DOUBLE-BLIND METHOD; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; NOMOGRAMS; PLACEBO EFFECT; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 39049109742     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21216     Document Type: Article

References (36)

1. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med 2006;354:44-53.
2. Weisfelt M, de Gans J, van der Poll T, van de Beek D. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol 2006;5:332-342.
3. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998;129:862-869.
4. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-1859.
5. Weisfelt M, van de Beek D, Spanjaard L, et al. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006;5:123-129.
6. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21-28.
7. Sigurdardottir B, Bjornsson OM, Jonsdottir KE, et al. Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med 1997;157:425-430.
8. Hussein AS, Shafran SD. Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore) 2000;79:360-368.
9. Olsson RA, Kirby JC, Romansky MJ. Pneumococcal meningitis in the adult. Clinical, therapeutic, and prognostic aspects in forty-three patients. Ann Intern Med 1961;55:545-549.
10. Weiss W, Figueroa W, Shapiro WH, Flippin HF. Prognostic factors in pneumococcal meningitis. Arch Intern Med 1967;120:517-524.
11. Magnussen CR. Meningitis in adults; ten-year retrospective analysis at community hospital. N Y State J Med 1980;80:901-906.
12. Bohr V, Rasmussen N, Hansen B, et al. Pneumococcal meningitis: an evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae. J Infect 1985;10:143-157.
13. Bruyn GA, Kremer HP, de Marie S, Padberg GW, et al. Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period. Eur J Clin Microbiol Infecr Dis 1989;8:695-700.
14. Hoen B, Viel JF, Gerard A, et al. Mortality in pneumococcal meningitis: a multivariate analysis of prognostic factors. Eur J Med 1993;2:28-32.
15. Kirkpatrick B, Reeves DS, MacGowan AP. A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect 1994;29:171-182.
16. Attia J, Hatala R, Cook DJ, Wong JG. The rational clinical examination. Does this adult patient have acute meningitis? JAMA 1999;282:175-181.
17. Kragsbjerg P, Kallman J, Oleen P. Pneumococcal meningitis in adults. Scand J Infect Dis 1994;26:659-666.
18. Auburtin M, Porcher R, Bruneel F, et al. Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am J Respir Crit Care Med 2002;165:713-717.
19. Lu CH, Huang CR, Chang WN, et al. Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. Clin Neurol Neurosurg 2002;104:352-358.
20. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003;126:1015-1025.
21. Flores-Cordero JM, Maya-Villar R, Rincon-Ferrari MD, et al. Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors. Intensive Care Med 2003;29:1967-1973.
22. Ostergaard C, Konradsen HB, Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis 2005;5:93.
23. Jennet B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-484.
24. de Gans J, van de Beek D. Dexamethasone in adults with bacrerial meningitis. N Engl J Med 2002;347:1549-1556.
25. Little R, Rubin D. Statistical analysis with missing data. New York: Wiley, 1987.
26. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carorid Surgery Trialists' Collaborative Group. Lancet 1999;353:2105-2110.
27. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000;19:453-473.
28. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993;118:201-210.
29. van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis 2004;4:139-143.
30. Weisfelt M, Hoogman M, van de Beek D, et al. Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol 2006;60:456-468.
31. Hoogman M, van de Beek D, Weisfelt M, et al. Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry (in press).
32. Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis 2007;7:191-200.
33. van de Beek D, de Gans J. Dexamethasone in adults with community-acquired bacterial meningitis. Drugs 2006;66:415-427.
34. Weisfelt M, van de Beek D, de Haan RJ, de Gans J. Dexamethasone and prognostic factors in adults with bacterial meningitis. J Neurol 2006;5:73-78.
35. van de Beek D, de Gans J, Spanjaard L, et al. Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother 2002;49:661-666.
36. Weisfelt M, van de Beek D, Spanjaard L, et al. Community-acquired bacterial meningitis in older people. J Am Geriatr Soc 2006;54:1500-1507.